OQS
ASTH icon

Occudo Quantitative Strategies’s Astrana Health ASTH Stock Holding History

Occudo Quantitative Strategies’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,362
Closed -$369K – 1001
2024
Q3 		$369K Buy
+6,362
New +$313K 0.07% 371
2022
Q4 		– Sell
-34,639
Closed -$1.35M – 1437
2022
Q3 		$1.35M Buy
+34,639
New +$1.59M 0.11% 283

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Occudo Quantitative Strategies's ASTH Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 6,362 shares — an estimated $369K sold.

Occudo Quantitative Strategies first reported a position in ASTH in Q3 2022 and held it in 2 quarters. The position peaked at $1.35M in Q3 2022. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 6,362 Astrana Health shares in Q4 2024, an estimated $369K.
  • Occudo Quantitative Strategies first reported a position in Astrana Health in Q3 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Astrana Health position peaked at $1.35M in Q3 2022.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.